This inventor holds 4 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent and 8 EPO patents. Top assignee: Metriopharm Ag. Active years: 2014-2026.
Company Filing History:
Years Active: 2014-2026
Title: Astrid Kaiser: Innovator in Pharmaceutical Treatments
Introduction
Astrid Kaiser is a notable inventor based in Berlin, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of chronic diseases. With a total of 4 patents to her name, her work is recognized for its potential impact on patient care.
Latest Patents
Kaiser's latest patents include innovative treatments using 5-amino-2,3-dihydro-1,4-phthalazinedione. One patent focuses on its application in treating rare chronic inflammatory pulmonary diseases. This invention specifically highlights the use of 5-amino-2,3-dihydro-1,4-phthalazinedione sodium salt for therapeutic purposes. Another patent addresses chronic progressive multiple sclerosis, detailing the use of the same compound for treating both primary and secondary progressive forms of the disease.
Career Highlights
Astrid Kaiser is currently associated with Metriopharm AG, where she continues to develop her groundbreaking research. Her work is characterized by a commitment to improving treatment options for patients suffering from chronic conditions.
Collaborations
Kaiser collaborates with esteemed colleagues such as Wolfgang Brysch and Beate Ludescher, who contribute to her research endeavors. Their combined expertise enhances the innovative potential of their projects.
Conclusion
Astrid Kaiser stands out as a pioneering inventor in the pharmaceutical industry, with her patents reflecting a dedication to advancing medical treatments. Her contributions are poised to make a significant difference in the lives of patients with chronic diseases.